Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 791978, 14 pages
http://dx.doi.org/10.1155/2015/791978
Review Article

Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall

Department of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume 447, 34149 Trieste, Italy

Received 25 September 2014; Accepted 26 January 2015

Academic Editor: Yong Q. Chen

Copyright © 2015 Michela Zanetti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Avolio, “Arterial stiffness,” Pulse, vol. 1, no. 1, pp. 14–28, 2013. View at Publisher · View at Google Scholar
  2. R. Kwak, M. Bäck, M.-L. Bochaton-Piallat et al., “Biomechanical factors in atherosclerosis: mechanisms and clinical implications,” European Heart Journal, vol. 35, no. 43, pp. 3013–3020, 2014. View at Publisher · View at Google Scholar
  3. E. Gutiérrez, A. J. Flammer, L. O. Lerman, J. Elízaga, A. Lerman, and F.-A. Francisco, “Endothelial dysfunction over the course of coronary artery disease,” European Heart Journal, vol. 34, no. 41, pp. 3175–3182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Deanfield, J. P. Halcox, and T. J. Rabelink, “Endothelial function and dysfunction: testing and clinical relevance,” Circulation, vol. 115, no. 10, pp. 1285–1295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Vlachopoulos, K. Aznaouridis, and C. Stefanadis, “Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis,” Journal of the American College of Cardiology, vol. 55, no. 13, pp. 1318–1327, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. P. O. Bonetti, L. O. Lerman, and A. Lerman, “Endothelial dysfunction: a marker of atherosclerotic risk,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 2, pp. 168–175, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Mozaffarian and J. H. Y. Wu, “Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events,” Journal of the American College of Cardiology, vol. 58, no. 20, pp. 2047–2067, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. F. O'Rourke and J. Hashimoto, “Mechanical factors in arterial aging: a clinical perspective,” Journal of the American College of Cardiology, vol. 50, no. 1, pp. 1–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Laurent, J. Cockcroft, L. Van Bortel et al., “Expert consensus document on arterial stiffness: methodological issues and clinical applications,” European Heart Journal, vol. 27, no. 21, pp. 2588–2605, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. G. Pickering, “Arteriosclerosis and atherosclerosis. The need for clear thinking,” The American Journal of Medicine, vol. 34, no. 1, pp. 7–18, 1963. View at Publisher · View at Google Scholar · View at Scopus
  11. I. B. Wilkinson, C. M. McEniery, and J. R. Cockcroft, “Arteriosclerosis and atherosclerosis: guilty by association,” Hypertension, vol. 54, no. 6, pp. 1213–1215, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. P. Pase, N. A. Grima, and J. Sarris, “The effects of dietary and nutrient interventions on arterial stiffness: a systematic review,” The American Journal of Clinical Nutrition, vol. 93, no. 2, pp. 446–454, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. R. de Caterina and A. Zampolli, “Omega-3 fatty acids, atherogenesis, and endothelial activation,” Journal of Cardiovascular Medicine, vol. 8, supplement 1, pp. S11–S14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Saravanan, N. C. Davidson, E. B. Schmidt, and P. C. Calder, “Cardiovascular effects of marine omega-3 fatty acids,” The Lancet, vol. 376, no. 9740, pp. 540–550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. W. S. Harris, M. Miller, A. P. Tighe, M. H. Davidson, and E. J. Schaefer, “Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives,” Atherosclerosis, vol. 197, no. 1, pp. 12–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Weintraub, “Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options,” Atherosclerosis, vol. 230, no. 2, pp. 381–389, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. G. K. Hansson, “Inflammation, atherosclerosis, and coronary artery disease,” The New England Journal of Medicine, vol. 352, no. 16, pp. 1685–1695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. L. Chang, T. Seo, M. Matsuzaki, T. S. Worgall, and R. J. Deckelbaum, “n-3 fatty acids reduce arterial LDL-cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 4, pp. 555–561, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. L. Chang, C. Torrejon, U. J. Jung, K. Graf, and R. J. Deckelbaum, “Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/-mice,” Atherosclerosis, vol. 234, no. 2, pp. 401–409, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. C. Doran, N. Meller, and C. A. McNamara, “Role of smooth muscle cells in the initiation and early progression of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 812–819, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. N. Diep, R. M. Touyz, and E. L. Schiffrin, “Docosahexaenoic acid, a peroxisome proliferator-activated receptor-α ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38: mitogen-activated protein kinase,” Hypertension, vol. 36, no. 5, pp. 851–855, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Shiina, T. Terano, J. Saito, Y. Tamura, and S. Yoshida, “Eicosapentaenoic acid and docosahexaenoic acid suppress the proliferation of vascular smooth muscle cells,” Atherosclerosis, vol. 104, no. 1-2, pp. 95–103, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Goua, S. Mulgrew, J. Frank, D. Rees, A. A. Sneddon, and K. W. J. Wahle, “Regulation of adhesion molecule expression in human endothelial and smooth muscle cells by omega-3 fatty acids and conjugated linoleic acids: involvement of the transcription factor NF-κB?” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 78, no. 1, pp. 33–43, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Thies, J. M. C. Garry, P. Yaqoob et al., “Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial,” The Lancet, vol. 361, no. 9356, pp. 477–485, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. A. L. Cawood, R. Ding, F. L. Napper et al., “Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability,” Atherosclerosis, vol. 212, no. 1, pp. 252–259, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Pignoli, E. Tremoli, A. Poli et al., “Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging,” Circulation, vol. 74, no. 6, pp. 1399–1406, 1986. View at Publisher · View at Google Scholar · View at Scopus
  27. E. M. Balk, A. H. Lichtenstein, M. Chung, B. Kupelnick, P. Chew, and J. Lau, “Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: a systematic review,” Atherosclerosis, vol. 184, no. 2, pp. 237–246, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Mita, H. Watada, T. Ogihara et al., “Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes,” Atherosclerosis, vol. 191, no. 1, pp. 162–167, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. E. M. Hjerkinn, M. Abdelnoor, L. Breivik et al., “Effect of diet or very long chain ω-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 13, no. 3, pp. 325–333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Sekikawa, T. Kadowaki, A. El-Saed et al., “Differential association of docosahexaenoic and eicosapentaenoic acids with carotid intima-media thickness,” Stroke, vol. 42, no. 9, pp. 2538–2543, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Benetos, S. Laurent, R. G. Asmar, and L. Patrick, “Large artery stiffness in hypertension,” Journal of Hypertension, Supplement, vol. 15, no. 2, pp. S89–S97, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Cabo, R. Alonso, and P. Mata, “Omega-3 fatty acids and blood pressure,” British Journal of Nutrition, vol. 107, supplement 2, pp. S195–S200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. P. E. Miller, M. Van Elswyk, and D. D. Alexander, “Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials,” American Journal of Hypertension, vol. 27, no. 7, pp. 885–896, 2014. View at Publisher · View at Google Scholar
  34. A. L. Catapano, Ž. Reiner, G. de Backer et al., “ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS),” Atherosclerosis, vol. 217, supplement 1, pp. 1–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Salomaa, W. Riley, J. D. Kark, C. Nardo, and A. R. Folsom, “Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC study,” Circulation, vol. 91, no. 5, pp. 1432–1443, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. S. P. Whelton, R. Blankstein, M. H. Al-Mallah et al., “Association of resting heart rate with carotid and aortic arterial stiffness: multi-ethnic study of atherosclerosis,” Hypertension, vol. 62, no. 3, pp. 477–484, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. P. L. McLennan, “Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models,” Lipids, vol. 36, supplement, pp. S111–S114, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Leaf, J. X. Kang, Y.-F. Xiao, and G. E. Billman, “Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils,” Circulation, vol. 107, no. 21, pp. 2646–2652, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Mozaffarian and J. H. Y. Wu, “Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events,” Journal of the American College of Cardiology, vol. 58, no. 20, pp. 2047–2067, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. A. A. Mangoni, L. Mircoli, C. Giannattasio, G. Mancia, and A. U. Ferrari, “Effect of sympathectomy on mechanical properties of common carotid and femoral arteries,” Hypertension, vol. 30, no. 5, pp. 1085–1088, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Peng, S. Haldar, S. Deshpande, K. Irani, and D. A. Kass, “Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium,” Hypertension, vol. 41, no. 2, pp. 378–381, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. I. B. Wilkinson, A. Qasem, C. M. McEniery, D. J. Webb, A. P. Avolio, and J. R. Cockcroft, “Nitric oxide regulates local arterial distensibility in vivo,” Circulation, vol. 105, no. 2, pp. 213–217, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Schmitt, A. Avolio, A. Qasem et al., “Basal NO locally modulates human iliac artery function in vivo,” Hypertension, vol. 46, no. 1, pp. 227–231, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Yaginuma, A. Avolio, M. O'Rourke et al., “Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man,” Cardiovascular Research, vol. 20, no. 2, pp. 153–160, 1986. View at Publisher · View at Google Scholar · View at Scopus
  45. T. A. Mori, G. F. Watts, V. Burke, E. Hilme, I. B. Puddey, and L. J. Beilin, “Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men,” Circulation, vol. 102, no. 11, pp. 1264–1269, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Kenny, D. C. Warltier, J. A. Pleuss, R. G. Hoffmann, T. L. Goodfriend, and B. M. Egan, “Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men,” The American Journal of Cardiology, vol. 70, no. 15, pp. 1347–1352, 1992. View at Publisher · View at Google Scholar · View at Scopus
  47. J. P. F. Chin, A. P. Gust, P. J. Nestel, and A. M. Dart, “Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans,” Hypertension, vol. 21, no. 1, pp. 22–28, 1993. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Sato, Y. Katsuki, H. Kanehiro et al., “Effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate on the physical properties of arterial walls in high cholesterol diet-fed rabbits,” Journal of Cardiovascular Pharmacology, vol. 22, no. 1, pp. 1–9, 1993. View at Google Scholar · View at Scopus
  49. V. R. Masson, A. Lucas, A.-M. Gueugneau et al., “Long-chain (n-3) polyunsaturated fatty acids prevent metabolic and vascular disorders in fructose-fed rats,” Journal of Nutrition, vol. 138, no. 10, pp. 1915–1922, 2008. View at Google Scholar · View at Scopus
  50. M. M. Engler, M. B. Engler, D. M. Pierson, L. B. Molteni, and A. Molteni, “Effects of docosahexaenoic acid on vascular pathology and reactivity in hypertension,” Experimental Biology and Medicine, vol. 228, no. 3, pp. 299–307, 2003. View at Google Scholar · View at Scopus
  51. P. Losurdo, A. Grillo, E. Panizon et al., “Supplementation of omega-3 polyunsaturated fatty acids prevents increase in arterial stiffness after experimental menopause,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 19, no. 1, pp. 114–120, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Losurdo, A. Grillo, E. Panizon et al., “Baroreflex sensitivity and central hemodynamics after omega-3 polyunsaturated fatty acids supplementation in an animal model of menopause,” Vascular Pharmacology, 2015. View at Publisher · View at Google Scholar
  53. M. P. Pase, N. A. Grima, and J. Sarris, “Do long-chain n-3 fatty acids reduce arterial stiffness? A meta-analysis of randomised controlled trials,” The British Journal of Nutrition, vol. 106, no. 7, pp. 974–980, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Siasos, D. Tousoulis, E. Oikonomou et al., “Effects of omega-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: a cross over study,” International Journal of Cardiology, vol. 166, no. 2, pp. 340–346, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Tousoulis, A. Plastiras, G. Siasos et al., “Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome,” Atherosclerosis, vol. 232, no. 1, pp. 10–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. A. T. Y. Wong, D. C. Chan, P. H. R. Barrett, L. A. Adams, and G. F. Watts, “Supplementation with n3 fatty acid ethyl esters increases large and small artery elasticity in obese adults on a weight loss diet,” Journal of Nutrition, vol. 143, no. 4, pp. 437–441, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Haiden, Y. Miyasaka, Y. Kimura et al., “Effect of eicosapentaenoic acid on regional arterial stiffness: assessment by tissue Doppler imaging,” World Journal of Cardiology, vol. 4, no. 8, pp. 256–259, 2012. View at Publisher · View at Google Scholar
  58. T. A. B. Sanders, W. L. Hall, Z. Maniou, F. Lewis, P. T. Seed, and P. J. Chowienczyk, “Effect of low doses of long-chain n-3 PUFAs on endothelial function and arterial stiffness: a randomized controlled trial,” The American Journal of Clinical Nutrition, vol. 94, no. 4, pp. 973–980, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Root, S. R. Collier, K. A. Zwetsloot, K. L. West, and M. C. McGinn, “A randomized trial of fish oil omega-3 fatty acids on arterial health, inflammation, and metabolic syndrome in a young healthy population,” Nutrition Journal, vol. 12, no. 1, article 40, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Dangardt, W. Osika, Y. Chen et al., “Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents,” Atherosclerosis, vol. 212, no. 2, pp. 580–585, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Fukuoka, N. Nuruki, S. Amiya et al., “Effects of a fish-based diet and administration of pure eicosapentaenoic acid on brachial-ankle pulse wave velocity in patients with cardiovascular risk factors,” Journal of Cardiology, vol. 63, no. 3, pp. 211–217, 2014. View at Google Scholar
  62. H. Tomiyama, C. Matsumoto, M. Odaira et al., “Relationships among the serum omega fatty acid levels, serum C-reactive protein levels and arterial stiffness/wave reflection in Japanese men,” Atherosclerosis, vol. 217, no. 2, pp. 433–436, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Sekikawa, C. Shin, K. H. Masaki et al., “Association of total marine fatty acids, eicosapentaenoic and docosahexaenoic acids, with aortic stiffness in Koreans, whites, and Japanese Americans,” American Journal of Hypertension, vol. 26, no. 11, pp. 1321–1327, 2013. View at Publisher · View at Google Scholar
  64. D. Tousoulis, A.-M. Kampoli, C. T. N. Papageorgiou, and C. Stefanadis, “The role of nitric oxide on endothelial function,” Current Vascular Pharmacology, vol. 10, no. 1, pp. 4–18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Karbach, P. Wenzel, A. Waisman, T. Munzel, and A. Daiber, “eNOS uncoupling in cardiovascular diseases—the role of oxidative stress and inflammation,” Current Pharmaceutical Design, vol. 20, no. 22, pp. 3579–3594, 2014. View at Publisher · View at Google Scholar
  66. U. Förstermann and T. Münzel, “Endothelial nitric oxide synthase in vascular disease: from marvel to menace,” Circulation, vol. 113, no. 13, pp. 1708–1714, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. E. Schulz, T. Jansen, P. Wenzel, A. Daiber, and T. Münzel, “Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension,” Antioxidants & Redox Signaling, vol. 10, no. 6, pp. 1115–1126, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Zhang, Y. Park, J. Wu et al., “Role of TNF-α in vascular dysfunction,” Clinical Science, vol. 116, no. 3, pp. 219–230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. J. A. Vita, “Endothelial function,” Circulation, vol. 124, no. 25, pp. e906–e912, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Strisciuglio, S. de Luca, E. Capuano et al., “Endothelial dysfunction: its clinical value and methods of assessment,” Current Atherosclerosis Reports, vol. 16, no. 6, article 417, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. G. Brevetti, A. Silvestro, V. Schiano, and M. Chiariello, “Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index,” Circulation, vol. 108, no. 17, pp. 2093–2098, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Yeboah, A. R. Folsom, G. L. Burke et al., “Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis,” Circulation, vol. 120, no. 6, pp. 502–509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. Y. Inaba, J. A. Chen, and S. R. Bergmann, “Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis,” International Journal of Cardiovascular Imaging, vol. 26, no. 6, pp. 631–640, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. J. J. L. Williams and T. M. Palmer, “Cavin-1: caveolae-dependent signalling and cardiovascular disease,” Biochemical Society Transactions, vol. 42, no. 2, pp. 284–288, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Layne, Z. Majkova, E. J. Smart, M. Toborek, and B. Hennig, “Caveolae: a regulatory platform for nutritional modulation of inflammatory diseases,” Journal of Nutritional Biochemistry, vol. 22, no. 9, pp. 807–811, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Ramadoss, M. B. Pastore, and R. R. Magness, “Endothelial caveolar subcellular domain regulation of endothelial nitric oxide synthase,” Clinical and Experimental Pharmacology and Physiology, vol. 40, no. 11, pp. 753–764, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. O. Feron, C. Dessy, S. Moniotte, J.-P. Desager, and J.-L. Balligand, “Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase,” The Journal of Clinical Investigation, vol. 103, no. 6, pp. 897–905, 1999. View at Publisher · View at Google Scholar · View at Scopus
  78. Y. Wu, C. Zhang, Y. Dong et al., “Activation of the AMP-activated protein kinase by eicosapentaenoic acid (EPA, 20:5 n-3) improves endothelial function in vivo,” PLoS ONE, vol. 7, no. 4, Article ID e35508, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Omura, S. Kobayashi, Y. Mizukami et al., “Eicosapentaenoic acid (EPA) induces Ca2+-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation,” FEBS Letters, vol. 487, no. 3, pp. 361–366, 2001. View at Publisher · View at Google Scholar · View at Scopus
  80. C. L. Stebbins, J. P. Stice, C. M. Hart, F. N. Mbai, and A. A. Knowlton, “Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 13, no. 4, pp. 261–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. L. Raimondi, M. Lodovici, F. Visioli et al., “n-3 polyunsaturated fatty acids supplementation decreases asymmetric dimethyl arginine and arachidonate accumulation in aging spontaneously hypertensive rats,” European Journal of Nutrition, vol. 44, no. 6, pp. 327–333, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. G. Gortan Cappellari, P. Losurdo, S. Mazzucco et al., “Treatment with n-3 polyunsaturated fatty acids reverses endothelial dysfunction and oxidative stress in experimental menopause,” Journal of Nutritional Biochemistry, vol. 24, no. 1, pp. 371–379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. W. Zhang, F. Fu, R. Tie et al., “Alpha-linolenic acid intake prevents endothelial dysfunction in high-fat diet-fed streptozotocin rats and underlying mechanisms,” Vasa, vol. 42, no. 6, pp. 421–428, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. M. D. Nyby, K. Matsumoto, K. Yamamoto et al., “Dietary fish oil prevents vascular dysfunction and oxidative stress in hyperinsulinemic rats,” American Journal of Hypertension, vol. 18, no. 2, pp. 213–219, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. D. López, X. Orta, K. Casós et al., “Upregulation of endothelial nitric oxide synthase in rat aorta after ingestion of fish oil-rich diet,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 287, no. 2, pp. H567–H572, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. D. López, C. Caballero, J. Sánchez, P. Puig-Parellada, and M. T. Mitjavila, “Free radical production in aortic rings from rats fed a fish oil-rich diet,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 280, no. 6, pp. H2929–H2935, 2001. View at Google Scholar · View at Scopus
  87. K. Casós, M. C. Zaragozá, N. Zarkovic et al., “A fish oil-rich diet reduces vascular oxidative stress in apoE−/−mice,” Free Radical Research, vol. 44, no. 7, pp. 821–829, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Matsumoto, N. Nakayama, K. Ishida, T. Kobayashi, and K. Kamata, “Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium- derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes,” Journal of Pharmacology and Experimental Therapeutics, vol. 329, no. 1, pp. 324–334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Serini, E. Fasano, E. Piccioni, A. R. M. Cittadini, and G. Calviello, “Dietary n-3 polyunsaturated fatty acids and the paradox of their health benefits and potential harmful effects,” Chemical Research in Toxicology, vol. 24, no. 12, pp. 2093–2105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. T.-M. Wang, C.-J. Chen, T.-S. Lee et al., “Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells,” Journal of Nutritional Biochemistry, vol. 22, no. 2, pp. 187–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. J. Shen, S. Shen, U. N. Das, and G. Xu, “Effect of essential fatty acids on glucose-induced cytotoxicity to retinal vascular endothelial cells,” Lipids in Health and Disease, vol. 11, article 90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. L. Lluís, N. Taltavull, M. Muñoz-Cortés et al., “Protective effect of the omega-3 polyunsaturated fatty acids: eicosapentaenoic acid/Docosahexaenoic acid 1 : 1 ratio on cardiovascular disease risk markers in rats,” Lipids in Health and Disease, vol. 12, article 140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. J. H. Y. Wu, L. E. Cahill, and D. Mozaffarian, “Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 6, pp. 2451–2459, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. E. A. Miles, T. Banerjee, and P. C. Calder, “The influence of different combinations of γ-linolenic, stearidonic and eicosapentaenoic acids on the fatty acid composition of blood lipids and mononuclear cells in human volunteers,” Prostaglandins, Leukotrienes & Essential Fatty Acids, vol. 70, no. 6, pp. 529–538, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. W. Xin, W. Wei, and X. Li, “Effect of fish oil supplementation on fasting vascular endothelial function in humans: a meta-analysis of randomized controlled trials,” PLoS ONE, vol. 7, no. 9, Article ID e46028, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. Q. Wang, X. Liang, L. Wang et al., “Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials,” Atherosclerosis, vol. 221, no. 2, pp. 536–543, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. W. S. Harris and C. von Schacky, “The Omega-3 Index: a new risk factor for death from coronary heart disease?” Preventive Medicine, vol. 39, no. 1, pp. 212–220, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. M. R. Flock, A. C. Skulas-Ray, W. S. Harris, T. D. Etherton, J. A. Fleming, and P. M. Kris-Etherton, “Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial,” The Journal of the American Heart Association, vol. 2, no. 6, Article ID e000513, 2013. View at Publisher · View at Google Scholar
  99. C.-Y. Wong, K.-H. Yiu, S.-W. Li et al., “Fish-oil supplement has neutral effects on vascular and metabolic function but improves renal function in patients with Type 2 diabetes mellitus,” Diabetic Medicine, vol. 27, no. 1, pp. 54–60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Stirban, S. Nandrean, C. Götting et al., “Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus,” The American Journal of Clinical Nutrition, vol. 91, no. 3, pp. 808–813, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. A. C. Skulas-Ray, P. M. Kris-Etherton, W. S. Harris, J. P. Vanden Heuvel, P. R. Wagner, and S. G. West, “Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia,” American Journal of Clinical Nutrition, vol. 93, no. 2, pp. 243–252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. K. Kawauchi, S. Tani, K. Nagao, and A. Hirayama, “Association of n-3 polyunsaturated fatty acids with soluble thrombomodulin as a marker of endothelial damage: a cross-sectional pilot study,” Journal of Cardiology, vol. 64, no. 4, pp. 312–317, 2014. View at Publisher · View at Google Scholar · View at Scopus
  103. D. Moertl, A. Hammer, S. Steiner, R. Hutuleac, K. Vonbank, and R. Berger, “Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study,” American Heart Journal, vol. 161, no. 5, pp. 915.e1–915.e9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Haberka, K. Mizia-Stec, M. Mizia et al., “N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction. N-3 PUFA supplementation in acute myocardial infarction,” Clinical Nutrition, vol. 30, no. 1, pp. 79–85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. J. N. Din, R. M. Archer, S. A. Harding et al., “Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokers,” Heart, vol. 99, no. 3, pp. 168–174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. D. Seely, S. Kanji, F. Yazdi et al., Dietary Supplements in Adults Taking Cardiovascular Drugs, US Agency for Healthcare Research and Quality, Rockville, Md, USA, 2012.
  107. E. C. Rizos, E. E. Ntzani, E. Bika, M. S. Kostapanos, and M. S. Elisaf, “Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis,” The Journal of the American Medical Association, vol. 308, no. 10, pp. 1024–1033, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. J. N. Din, J. Sarma, S. A. Harding, K. Lyall, D. E. Newby, and A. D. Flapan, “Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in patients with a previous myocardial infarction: a randomised controlled trial,” BMJ Open, vol. 3, no. 9, Article ID e003054, 2013. View at Publisher · View at Google Scholar · View at Scopus
  109. T. U. Singh, K. Kathirvel, S. Choudhury, S. K. Garg, and S. K. Mishra, “Eicosapentaenoic acid-induced endothelium-dependent and -independent relaxation of sheep pulmonary artery,” European Journal of Pharmacology, vol. 636, no. 1–3, pp. 108–113, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. G. E. McVeigh, G. M. Brennan, J. N. Cohn, S. M. Finkelstein, R. J. Hayes, and G. D. Johnston, “Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 14, no. 9, pp. 1425–1429, 1994. View at Publisher · View at Google Scholar · View at Scopus
  111. P. Nestel, H. Shige, S. Pomeroy, M. Cehun, M. Abbey, and D. Raederstorff, “The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans,” American Journal of Clinical Nutrition, vol. 76, no. 2, pp. 326–330, 2002. View at Google Scholar · View at Scopus
  112. A. M. Hill, J. D. Buckley, K. J. Murphy, and P. R. C. Howe, “Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors,” The American Journal of Clinical Nutrition, vol. 85, no. 5, pp. 1267–1274, 2007. View at Google Scholar · View at Scopus
  113. S. Wang, A. Q. Ma, S. W. Song, Q. H. Quan, X. F. Zhao, and X. H. Zheng, “Fish oil supplementation improves large arterial elasticity in overweight hypertensive patients,” European Journal of Clinical Nutrition, vol. 62, no. 12, pp. 1426–1431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. N. Satoh, A. Shimatsu, K. Kotani et al., “Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome,” Hypertension Research, vol. 32, no. 11, pp. 1004–1008, 2009. View at Publisher · View at Google Scholar · View at Scopus
  115. J. G. Ayer, J. A. Harmer, W. Xuan et al., “Dietary supplementation with n-3 polyunsaturated fatty acids in early childhood: effects on blood pressure and arterial structure and function at age 8 y,” American Journal of Clinical Nutrition, vol. 90, no. 2, pp. 438–446, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. N. J. Sjoberg, C. M. Milte, J. D. Buckley, P. R. C. Howe, A. M. Coates, and D. A. Saint, “Dose-dependent increases in heart rate variability and arterial compliance in overweight and obese adults with DHA-rich fish oil supplementation,” British Journal of Nutrition, vol. 103, no. 2, pp. 243–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. R. J. Woodman, T. A. Mori, V. Burke et al., “Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients,” Atherosclerosis, vol. 166, no. 1, pp. 85–93, 2003. View at Publisher · View at Google Scholar · View at Scopus
  118. M. M. Engler, M. B. Engler, M. Malloy et al., “Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the early study,” International Journal of Clinical Pharmacology and Therapeutics, vol. 42, no. 12, pp. 672–679, 2004. View at Publisher · View at Google Scholar · View at Scopus
  119. E. Ros, I. Núñez, A. Pérez-Heras et al., “A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial,” Circulation, vol. 109, no. 13, pp. 1609–1614, 2004. View at Publisher · View at Google Scholar · View at Scopus
  120. J. B. Keogh, J. A. Grieger, M. Noakes, and P. M. Clifton, “Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 6, pp. 1274–1279, 2005. View at Publisher · View at Google Scholar · View at Scopus
  121. A. Prabodh Shah, A. M. Ichiuji, J. K. Han et al., “Cardiovascular and endothelial effects of fish oil supplementation in healthy volunteers,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 12, no. 3, pp. 213–219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. S. Wright, F. M. O'Prey, M. T. McHenry et al., “A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 67, no. 6, pp. 841–848, 2008. View at Publisher · View at Google Scholar · View at Scopus
  123. V. Schiano, E. Laurenzano, G. Brevetti et al., “Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function,” Clinical Nutrition, vol. 27, no. 2, pp. 241–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  124. C. Mindrescu, R. P. Gupta, E. V. Hermance et al., “Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia,” Vascular Health and Risk Management, vol. 4, no. 6, pp. 1439–1447, 2008. View at Google Scholar · View at Scopus
  125. S. Rizza, M. Tesauro, C. Cardillo et al., “Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes,” Atherosclerosis, vol. 206, no. 2, pp. 569–574, 2009. View at Publisher · View at Google Scholar · View at Scopus